Marketing Manager - Germline
Tempus AI
Summary
The Marketing Manager - Germline plays a critical downstream commercial execution role driving market adoption, campaign success, and field enablement for our hereditary cancer testing (HCT) and expanded germline genetics portfolio. Working closely with senior marketing leadership, Medical Affairs, Product, and Sales, this role translates complex genomic science—including Next-Generation Sequencing (NGS) workflows, Variant of Uncertain Significance (VUS) resolution, and cascade/family-member testing programs—into compelling HCP- and patient-facing materials.
Job description
Responsibilities
- Multi-Channel Campaigns: Execute downstream GTM tactical plans to increase clinical adoption of hereditary screening tools and point-of-care germline workflows.
- Collateral Development: Create HCP sell sheets, pitch decks, white papers, patient education guides, and digital portal assets that clearly articulate our unique clinical value proposition.
- Digital & Patient Engagement: Partner with digital marketing teams to optimize clinician portals, streamline genetic counseling integration, and improve online patient experience.
- Sales Enablement: Equip the commercial team with high-impact sales aids, objection-handling tools, and competitive differentiation materials.
- Training Support: Collaborate with Learning & Development (L&D) to ensure sales representatives are well-trained on product positioning and clinical narratives.
- Feedback Loop: Regularly engage with regional sales reps and medical science liaisons to gather field insights and refine messaging.
- Cross-Functional Collaboration: Work alongside R&D, Medical Affairs, and Genetic Counseling teams to ensure all messaging is scientifically validated.
- Regulatory & Legal Review: Direct promotional assets through internal legal, compliance, and regulatory review processes (CLIA/CAP/FDA compliance standards).
- Events & Congresses: Oversee conference booth strategy, promotional collateral, and sponsored symposia at major oncology and genetics meetings (e.g., ACMG, NSGC, ASCO).
- KOL & Speaker Support: Support key opinion leader (KOL) engagement initiatives and educational webinars.
Required Skills
- Downstream Execution: Proven track record of launching marketing collateral and driving multi-channel GTM campaigns.
- Cross-Functional Project Management: Strong ability to lead projects to completion across technical, medical, legal, and commercial teams.
- Communication & Storytelling: Ability to simplify complex genomic data into clear, persuasive, and actionable clinical narratives.
- Digital & AI Tooling: Modern approach to leveraging CRM systems, digital automation, and AI-driven workflow tools for commercial efficiency.
Required Education & Experience
- Bachelor’s degree in Life Sciences, Marketing, Communications, or a related field.
- 4–7+ years of downstream product marketing experience in healthcare, clinical diagnostics, or life sciences.
- Baseline understanding of Next-Generation Sequencing (NGS), cancer genomics, or hereditary cancer testing (HCT) concepts.
Requirements
- Bachelor’s degree in Life Sciences, Marketing, Communications, or a related field
- 4–7+ years of downstream product marketing experience in healthcare, clinical diagnostics, or life sciences
- Baseline understanding of Next-Generation Sequencing (NGS), cancer genomics, or hereditary cancer testing (HCT) concepts
- Proven track record of launching marketing collateral and driving multi-channel GTM campaigns
- Strong ability to lead projects to completion across technical, medical, legal, and commercial teams
- Ability to simplify complex genomic data into clear, persuasive, and actionable clinical narratives
- Modern approach to leveraging CRM systems, digital automation, and AI-driven workflow tools for commercial efficiency
Benefits
- Incentive Compensation
- Restricted Stock Units
- Medical Benefits
Company overview
Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.